deltatrials
Terminated PHASE4 INTERVENTIONAL 1-arm NCT00726804

Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis (SPARTA)

Discontinuation of TNF-alpha Inhibitors in Spondylarthritis Patients With Low Disease Activity, and Re-initiation of Therapy if Disease Flares

Sponsor: Glostrup University Hospital, Copenhagen

Conditions SPONDYLOARTHRITIS
Interventions Discontinuation of TNF-alpha inhibitor and re-starting it if flare-up in disease activity (etanercept or adalimumab)
Updated 5 times since 2017 Last updated: Aug 18, 2015 Started: Mar 31, 2008 Primary completion: May 31, 2012 Completion: May 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

It was not possible to recruit patients

Other terminated trials from Glostrup University Hospital, Copenhagen

See all terminations from Glostrup University Hospital, Copenhagen

This PHASE4 trial investigates SPONDYLOARTHRITIS and is currently terminated or withdrawn. Glostrup University Hospital, Copenhagen leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE4

    First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Glostrup University Hospital, Copenhagen
Data source: Glostrup University Hospital, Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations